Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Stefanska

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Nutrients|March 26, 2022
Relationships between Bone Turnover Markers and Factors Associated with Metabolic Syndrome in Prepubertal Girls and BoysWojciech J Bilinski, Anna Stefanska, Lukasz Szternel, et al.
Clinical Chemistry and Laboratory Medicine|October 15, 2025
Biological variation of serum transthyretin concentrationsAnna Stefanska, Joanna Siodmiak, Łukasz Szternel, et al.
Clinical Chemistry and Laboratory Medicine|August 25, 2025
Biological variation of serum Golgi protein 73 concentrationsAnna Stefanska, Joanna Siodmiak, Katarzyna Bergmann, et al.
Pancreas|April 18, 2014
Impact of fructose diet and renal failure on the function of pancreatic isletsMarta Pokrywczynska, Mariusz Flisinski, Arkadiusz Jundzill, et al.
The Lancet. Rheumatology|January 26, 2024
5-year efficacy and safety of secukinumab in patients with ankylosing spondylitis: end-of-study results from the phase 3 MEASURE 2 trialHelena Marzo-Ortega, Joachim Sieper, Alan J Kivitz, et al.
ACR Open Rheumatology|January 21, 2020
Secukinumab 150/300 mg Provides Sustained Improvements in the Signs and Symptoms of Active Ankylosing Spondylitis: 3-Year Results from the Phase 3 MEASURE 3 StudyKarel Pavelka, Alan J Kivitz, Eva Dokoupilova, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 2011
Regulation of chemerin chemoattractant and antibacterial activity by human cysteine cathepsinsPaulina Kulig, Tomasz Kantyka, Brian A Zabel, et al.
Blood|December 17, 2008
Vascular endothelial growth factor-D transgenic mice show enhanced blood capillary density, improved postischemic muscle regeneration, and increased susceptibility to tumor formationAnna-Mari Kärkkäinen, Antti Kotimaa, Jenni Huusko, et al.
The Journal of Experimental Medicine|May 22, 2013
Retinoic acid expression associates with enhanced IL-22 production by γδ T cells and innate lymphoid cells and attenuation of intestinal inflammationLisa A Mielke, Sarah A Jones, Mathilde Raverdeau, et al.
Arthritis Research & Therapy|May 16, 2023
Two-year imaging outcomes from a phase 3 randomized trial of secukinumab in patients with non-radiographic axial spondyloarthritisJuergen Braun, Ricardo Blanco, Helena Marzo-Ortega, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Nutrients|March 26, 2022
Relationships between Bone Turnover Markers and Factors Associated with Metabolic Syndrome in Prepubertal Girls and BoysWojciech J Bilinski, Anna Stefanska, Lukasz Szternel, et al.
Clinical Chemistry and Laboratory Medicine|October 15, 2025
Biological variation of serum transthyretin concentrationsAnna Stefanska, Joanna Siodmiak, Łukasz Szternel, et al.
Clinical Chemistry and Laboratory Medicine|August 25, 2025
Biological variation of serum Golgi protein 73 concentrationsAnna Stefanska, Joanna Siodmiak, Katarzyna Bergmann, et al.
Pancreas|April 18, 2014
Impact of fructose diet and renal failure on the function of pancreatic isletsMarta Pokrywczynska, Mariusz Flisinski, Arkadiusz Jundzill, et al.
The Lancet. Rheumatology|January 26, 2024
5-year efficacy and safety of secukinumab in patients with ankylosing spondylitis: end-of-study results from the phase 3 MEASURE 2 trialHelena Marzo-Ortega, Joachim Sieper, Alan J Kivitz, et al.
ACR Open Rheumatology|January 21, 2020
Secukinumab 150/300 mg Provides Sustained Improvements in the Signs and Symptoms of Active Ankylosing Spondylitis: 3-Year Results from the Phase 3 MEASURE 3 StudyKarel Pavelka, Alan J Kivitz, Eva Dokoupilova, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 2011
Regulation of chemerin chemoattractant and antibacterial activity by human cysteine cathepsinsPaulina Kulig, Tomasz Kantyka, Brian A Zabel, et al.
Blood|December 17, 2008
Vascular endothelial growth factor-D transgenic mice show enhanced blood capillary density, improved postischemic muscle regeneration, and increased susceptibility to tumor formationAnna-Mari Kärkkäinen, Antti Kotimaa, Jenni Huusko, et al.
The Journal of Experimental Medicine|May 22, 2013
Retinoic acid expression associates with enhanced IL-22 production by γδ T cells and innate lymphoid cells and attenuation of intestinal inflammationLisa A Mielke, Sarah A Jones, Mathilde Raverdeau, et al.
Arthritis Research & Therapy|May 16, 2023
Two-year imaging outcomes from a phase 3 randomized trial of secukinumab in patients with non-radiographic axial spondyloarthritisJuergen Braun, Ricardo Blanco, Helena Marzo-Ortega, et al.
Pageof 4